Shares of BioXcel Therapeutics Inc. (BTAI) have gained nearly 86 percent over the last 1 month as the Company gears up for reporting trial results of one of its most advanced clinical development programs BXCL501.
from RTT - Biotech https://ift.tt/2wPG3GI
via IFTTT
No comments:
Post a Comment